Component
Inhibitory heterotrimeric G protein / Gi, assay-specified subunits
Inhibitory heterotrimeric G protein / Gi, assay-specified subunits. Species, exposure and limitations are retained in each linked claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Agonist-bound human MT1 was structurally resolved in a Gi signaling complex.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/35075127.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "08af0c72228d7c72723f238e83eeabef1ca9196833c7e385ed0c75577c97024b", "start_char": 0, "end_char": 1239, "text_sha256": "08af0c72228d7c72723f238e83eeabef1ca9196833c7e385ed0c75577c97024b"}
- experimental_model
- Cryo-EM structures and functional receptor assays
- exposure
- 2-iodomelatonin/ramelteon for MT1; ramelteon for MT2
- limitations
- Structures used agonists, not native melatonin in every complex. Receptor structure does not itself prove clinical effects or subtype-selective supplement actions.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human MT1 and MT2 signaling complexes
- plain_language
- The receptor and its signaling partner are separate searchable components.
- primary_references
- [melatonin-p35075127] Structural basis of the ligand binding and signaling mechanism of melatonin receptors. (2022). https://pubmed.ncbi.nlm.nih.gov/35075127/ DOI: 10.1038/s41467-022-28111-3
- tissue_or_cell_type
- Agonist-bound receptor-Gi coupling
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 396–407
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cryo-EM structures and functional receptor assays · source_derived_draft · unverified_draft
### melatonin-mt1-gi-structure Agonist-bound human MT1 was structurally resolved in a Gi signaling complex. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The receptor and its signaling partner are separate searchable components. organism: Human MT1 and MT2 signaling complexes tissue_or_cell_type: Agonist-bound receptor-Gi coupling experimental_model: Cryo-EM structures and functional receptor assays limitations: Structures used agonists, not native melatonin in every complex. Receptor structure does not itself prove clinical effects or subtype-selective supplement actions. exposure: 2-iodomelatonin/ramelteon for MT1; ramelteon for MT2 evidence_span: {"source_cache": "artifacts/melatonin-research/35075127.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "08af0c72228d7c72723f238e83eeabef1ca9196833c7e385ed0c75577c97024b", "start_char": 0, "end_char": 1239, "text_sha256": "08af0c72228d7c72723f238e83eeabef1ca9196833c7e385ed0c75577c97024b"} [melatonin-p35075127] Structural basis of the ligand binding and signaling mechanism of melatonin receptors. (2022). https://pubmed.ncbi.nlm.nih.gov/35075127/ DOI: 10.1038/s41467-022-28111-3
Complete structured claim and evidenceAgonist-bound human MT2 was structurally resolved in a Gi signaling complex.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/melatonin-research/35075127.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "08af0c72228d7c72723f238e83eeabef1ca9196833c7e385ed0c75577c97024b", "start_char": 0, "end_char": 1239, "text_sha256": "08af0c72228d7c72723f238e83eeabef1ca9196833c7e385ed0c75577c97024b"}
- experimental_model
- Cryo-EM structures and functional receptor assays
- exposure
- 2-iodomelatonin/ramelteon for MT1; ramelteon for MT2
- limitations
- Structures used agonists, not native melatonin in every complex. Receptor structure does not itself prove clinical effects or subtype-selective supplement actions.
- nutrient_topic
- Melatonin research collection; topical membership is not evidence of a direct dietary effect. · Melatonin
- organism
- Human MT1 and MT2 signaling complexes
- plain_language
- The receptor and its signaling partner are separate searchable components.
- primary_references
- [melatonin-p35075127] Structural basis of the ligand binding and signaling mechanism of melatonin receptors. (2022). https://pubmed.ncbi.nlm.nih.gov/35075127/ DOI: 10.1038/s41467-022-28111-3
- tissue_or_cell_type
- Agonist-bound receptor-Gi coupling
Melatonin: synthesis, receptors, circadian timing and nutrient interactions (2026-09-17) · lines 409–420
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cryo-EM structures and functional receptor assays · source_derived_draft · unverified_draft
### melatonin-mt2-gi-structure Agonist-bound human MT2 was structurally resolved in a Gi signaling complex. Condition category: normal nutrient_topic: Melatonin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The receptor and its signaling partner are separate searchable components. organism: Human MT1 and MT2 signaling complexes tissue_or_cell_type: Agonist-bound receptor-Gi coupling experimental_model: Cryo-EM structures and functional receptor assays limitations: Structures used agonists, not native melatonin in every complex. Receptor structure does not itself prove clinical effects or subtype-selective supplement actions. exposure: 2-iodomelatonin/ramelteon for MT1; ramelteon for MT2 evidence_span: {"source_cache": "artifacts/melatonin-research/35075127.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "08af0c72228d7c72723f238e83eeabef1ca9196833c7e385ed0c75577c97024b", "start_char": 0, "end_char": 1239, "text_sha256": "08af0c72228d7c72723f238e83eeabef1ca9196833c7e385ed0c75577c97024b"} [melatonin-p35075127] Structural basis of the ligand binding and signaling mechanism of melatonin receptors. (2022). https://pubmed.ncbi.nlm.nih.gov/35075127/ DOI: 10.1038/s41467-022-28111-3
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.